Mark McClellan, MD, PhD

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.

The authors apply HHS’s payment taxonomy framework to acute unscheduled care and describe how payment reform supports delivery innovation.

Gaps in accountable care measure sets can be addressed efficiently using priority measure types and innovative approaches to measurement.

The authors examine 4 alternative payment models for oncology care that shift away from fee-for-service and move progressively toward greater bundling, either across providers or across payments.

Authors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.

A group of experts who have spent their careers studying the healthcare system have convened to identify a path for sustainable reform in healthcare cost growth.